Ledipasvir and sofosbuvir in patients with genotype 1 hepatitis C virus infection and compensated cirrhosis: An integrated safety and efficacy analysis

  • K. Rajender Reddy
  • , Marc Bourlière
  • , Mark Sulkowski
  • , Masao Omata
  • , Stefan Zeuzem
  • , Jordan J. Feld
  • , Eric Lawitz
  • , Patrick Marcellin
  • , Tania M. Welzel
  • , Robert Hyland
  • , Xiao Ding
  • , Jenny Yang
  • , Steven Knox
  • , Phillip Pang
  • , Hadas Dvory-Sobol
  • , G. Mani Subramanian
  • , William Symonds
  • , John G. Mchutchison
  • , Alessandra Mangia
  • , Edward Gane
    • Masashi Mizokami, Stanislas Pol, Nezam Afdhal

Research output: Contribution to journal › Article › peer-review

230 Scopus citations

Fingerprint

Dive into the research topics of 'Ledipasvir and sofosbuvir in patients with genotype 1 hepatitis C virus infection and compensated cirrhosis: An integrated safety and efficacy analysis'. Together they form a unique fingerprint.

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience

Biochemistry, Genetics and Molecular Biology